A COVID-19 vaccine produced by Shenzhen Kangtai Biological Products was launched through the inoculation program in Luohu starting from June 1.

This vaccine obtained approval for emergency use from the country's drug authority on May 7, becoming the sixth approved COVID-19 vaccine.

Kangtai has also obtained the exclusive right to develop and manufacture the vaccine developed by AstraZeneca and Oxford University on the Chinese mainland.

The company initiated the research and development of the vaccine in February 2020. Now, it is striving to increase production capacity.

Some Luohu residents who took a jab of the Kangtai vaccine on June 1 said they have confidence in its safety and efficacy.